Show simple item record

dc.contributor.authorStenholm, Sari
dc.contributor.authorHarris, Tamara
dc.contributor.authorRantanen, Taina
dc.contributor.authorVisser, Marjolein
dc.contributor.authorKritchevsky, Steven B
dc.contributor.authorFerrucci, Luigi
dc.date.accessioned2019-09-25T11:18:05Z
dc.date.available2019-09-25T11:18:05Z
dc.date.issued2008fi
dc.identifier.citationStenholm, S., Harris, T., Rantanen, T., Visser, M., Kritchevsky, S. B., & Ferrucci, L. (2008). Sarcopenic obesity: definition, cause and consequences. <em>Current Opinion in Clinical Nutrition & Metabolic Care</em>, 11 (6), 693-700. <a href="https://doi.org/10.1097/MCO.0b013e328312c37d">https://doi.org/10.1097/MCO.0b013e328312c37d</a>fi
dc.identifier.otherTUTKAID_31818
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/65646
dc.description.abstractPURPOSE OF REVIEW: Older obese persons with decreased muscle mass or strength are at special risk for adverse outcomes. We discuss potential pathways to muscle impairment in obese individuals and the consequences that joint obesity and muscle impairment may have on health and disability. Tantamount to this discussion is whether low muscle mass or, rather, muscle weakness should be used for the definition. RECENT FINDINGS: Excess energy intake, physical inactivity, low-grade inflammation, insulin resistance and changes in hormonal milieu may lead to the development of so-called 'sarcopenic obesity'. It was originally believed that the culprit of age-related muscle weakness was a reduction in muscle mass, but it is now clear that changes in muscle composition and quality are predominant. We propose that the risk of adverse outcomes, such as functional limitation and mortality, is better estimated by considering jointly obesity and muscle strength rather than obesity and muscle mass and the term 'sarcopenic obesity' should be revisited. SUMMARY: Recognition of obese patients who have associated muscle problems is an essential goal for clinicians. Further research is needed to identify new target for prevention and cure of this important geriatric syndrome.fi
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.relation.ispartofseriesCurrent Opinion in Clinical Nutrition & Metabolic Care
dc.rightsIn Copyright
dc.subject.otherikääntyminenfi
dc.subject.othervanheneminenfi
dc.subject.othersarkopeniafi
dc.subject.otheragingfi
dc.subject.otherageingfi
dc.subject.othersarcopeniafi
dc.titleSarcopenic obesity: definition, cause and consequences.fi
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-201909114104
dc.contributor.laitosTerveystieteiden laitosfi
dc.contributor.laitosDepartment of Health Sciencesen
dc.contributor.oppiaineGerontologia ja kansanterveys
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.date.updated2019-09-11T09:15:29Z
dc.description.reviewstatuspeerReviewed
dc.format.pagerange693-700
dc.relation.issn1473-6519
dc.relation.numberinseries6
dc.relation.volume11
dc.type.versionacceptedVersion
dc.rights.copyright© 2008 Wolters Kluwer Health, Lippincott Williams & Wilkins
dc.rights.accesslevelopenAccessfi
dc.format.contentfulltext
dc.rights.urlhttp://rightsstatements.org/page/InC/1.0/?language=en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

In Copyright
Except where otherwise noted, this item's license is described as In Copyright